Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grass MATA MPL Immunogenicity in Grass and Rye Pollen Allergy
NCT00104377Phase 2Completed
- Sponsor
- Allergy Therapeutics PLC
- Start
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Grass MATA MPL in seasonal allergic rhinitis (SAR), sponsored by Allergy Therapeutics PLC. Started Mar 2005; status: completed.
02
Drugs
Grass MATA MPL
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00104377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104377.